Cite
Vasudevan D, Naik MM, Mukaddam QI. Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study. Ann Indian Acad Neurol. 2014;17(4):480-1doi: 10.4103/0972-2327.144048.
Vasudevan, D., Naik, M. M., & Mukaddam, Q. I. (2014). Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study. Annals of Indian Academy of Neurology, 17(4), 480-1. https://doi.org/10.4103/0972-2327.144048
Vasudevan, D, et al. "Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study." Annals of Indian Academy of Neurology vol. 17,4 (2014): 480-1. doi: https://doi.org/10.4103/0972-2327.144048
Vasudevan D, Naik MM, Mukaddam QI. Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study. Ann Indian Acad Neurol. 2014 Oct;17(4):480-1. doi: 10.4103/0972-2327.144048. PMID: 25506182; PMCID: PMC4251034.
Copy
Download .nbib